Prevenar 13

Pfizer study reveals pneumonia drug effective for the elderly

Pfizer Inc. said it is planning on presenting the results of its Community-Acquired Pneumonia Immunization Trial in Adults study next month, and that it may have significant impact on preventing community-acquired pneumonia for seniors.